- Full Year 2024 Astellas Pharma Inc Earnings Presentation TranscriptApr 25, 2024
- Astellas Pharma Inc Sustainability Meeting TranscriptFeb 21, 2024
- Q3 2024 Astellas Pharma Inc Earnings Presentation TranscriptFeb 05, 2024
- Astellas Pharma Inc IZERVAY Briefing TranscriptNov 05, 2023
- Q2 2024 Astellas Pharma Inc Earnings Presentation TranscriptNov 01, 2023
- Q1 2024 Astellas Pharma Inc Earnings Presentation TranscriptAug 01, 2023
- Astellas Pharma Inc to Acquire IVERIC bio Inc M&A Presentation TranscriptMay 01, 2023
- Full Year 2023 Astellas Pharma Inc Earnings Presentation TranscriptApr 27, 2023
- Astellas Pharma Inc Corporate- wide Digital Transformation Driven by Analytics Briefing TranscriptMar 27, 2023
- Astellas Pharma Inc Sustainability Meeting TranscriptFeb 17, 2023
- Q3 2023 Astellas Pharma Inc Earnings Presentation TranscriptFeb 06, 2023
- Astellas Pharma Inc R&D Briefing TranscriptDec 09, 2022
- Q2 2023 Astellas Pharma Inc Earnings Presentation TranscriptOct 31, 2022
- Astellas Pharma Inc Fezolinetant Briefing TranscriptOct 17, 2022
- Q1 2023 Astellas Pharma Inc Earnings Presentation TranscriptAug 01, 2022
- Full Year 2022 Astellas Pharma Inc Earnings Presentation TranscriptApr 27, 2022
- Astellas Pharma Inc R&D Meeting TranscriptMar 09, 2022
- Astellas Pharma Inc Sustainability Briefing TranscriptFeb 28, 2022
- Q3 2022 Astellas Pharma Inc Earnings Presentation TranscriptFeb 02, 2022
- Astellas Pharma Inc R&D Meeting TranscriptDec 07, 2021
- Q2 2022 Astellas Pharma Inc Earnings Presentation TranscriptOct 29, 2021
- Q1 2022 Astellas Pharma Inc Earnings Call TranscriptJul 30, 2021円1739 (-8.81%)Earnings
- Astellas Pharma Inc. Corporate Strategic Plan Presentation TranscriptMay 26, 2021
- Full Year 2021 Astellas Pharma Inc Earnings Call TranscriptApr 27, 2021円1597 (-3.15%)Earnings
- Q3 2021 Astellas Pharma Inc Earnings Call TranscriptJan 29, 2021円1692.5 (-0.88%)Earnings
- Astellas Pharma Inc R&D Meeting TranscriptDec 10, 2020
- Q2 2021 Astellas Pharma Inc Earnings Presentation TranscriptOct 30, 2020
- Q1 2021 Astellas Pharma Inc Earnings Call TranscriptAug 04, 2020円1709 (-0.32%)Earnings
- Full Year 2020 Astellas Pharma Inc Earnings Call TranscriptMay 18, 2020円1721.5 (-0.38%)Earnings
- Q3 2020 Astellas Pharma Inc Earnings Call TranscriptJan 31, 2020円1950.5 (+2.39%)Earnings
- Astellas Pharma Inc Approaches to Immuno-Oncology R&D Conference Call TranscriptDec 10, 2019
- Astellas Pharma Inc Acquisition of Audentes Therapeutics Inc Call TranscriptDec 03, 2019
- Q2 2020 Astellas Pharma Inc Earnings Call TranscriptOct 31, 2019円1858.5 (+0.87%)Earnings
- Astellas Pharma Inc Enfortumab Vedotin Call TranscriptOct 01, 2019
- Q1 2020 Astellas Pharma Inc Earnings Call TranscriptJul 30, 2019円1527 (+0.23%)Earnings
- Full Year 2019 Astellas Pharma Inc Earnings Call TranscriptApr 25, 2019円1481.5 (-2.53%)Earnings
Q1 2020 Astellas Pharma Inc Earnings Call Transcript
Once again, I'm Takeda. Thank you very much, indeed, for participating in this conference call today. I spend about 20 to 30 minutes to give you an overview of the financial results and explain our initiatives for sustainable growth.
Please turn to Page 4. Q1 fiscal year 2019 financial results on a core basis. Let me give you an overview. On a consolidated basis, revenues increased to JPY 334.1 billion, up 1.5% year-on-year. Core operating profit increased by 0.8% to JPY 84.7 billion. Core profit for the period was 67.1% (sic) [JPY 67.1 billion], down 4.6% year-on-year. Corporate tax rate increased from the previous year. There were one-off special items in the previous fiscal year. The corporate tax rate was low. As a result, the corporate tax rate rose year-on-year. Core operating profit increased to this level, but the higher corporate tax rate led to a decrease in the core profit for the period. Core EPS was remaining flat, minus 4.6% (sic) [minus 0.3%] year-on-year. A decrease in quarterly profit was offset by the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)